HHS will allow licensed pharmacies to compound six unapproved peptides—but says the policy does not mean they are safe or FDA-approved
The U.S. Department of Health and Human Services will allow state-licensed compounding pharmacies to make six unapproved peptides, including the widely promoted BPC-157, under a…
DO
By Daniel Okafor · Regulatory Correspondent
Oct 29 10:46 ETSource: Medical Daily
From the source
Read at medicaldaily.comHHS will allow licensed pharmacies to compound six unapproved peptides—but says the policy does not mean they are safe or FDA-approved
The U.S. Department of Health and Human Services will allow state-licensed compounding pharmacies to make six unapproved peptides, including the widely promoted BPC-157, under a temporary policy made public on October 28. The decision gives patients a legal prescription route to substances that the FDA's own scientists said lacked the human evidence needed to judge their safety.
